Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma
Ikeda, Kenji, Kudo, Masatoshi, Kawazoe, Seiji, Osaki, Yukio, Ikeda, Masafumi, Okusaka, Takuji, Tamai, Toshiyuki, Suzuki, Takuya, Hisai, Takashi, Hayato, Seiichi, Okita, Kiwamu, Kumada, Hiromitsu
Published in Journal of gastroenterology (01.04.2017)
Published in Journal of gastroenterology (01.04.2017)
Get full text
Journal Article
A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-Stage Hepatocellular Carcinoma: TACTICS-L Trial
Kudo, Masatoshi, Ueshima, Kazuomi, Saeki, Issei, Ishikawa, Toru, Inaba, Yoshitaka, Morimoto, Naoki, Aikata, Hiroshi, Tanabe, Nobukazu, Wada, Yoshiyuki, Kondo, Yasuteru, Tsuda, Masahiro, Nakao, Kazuhiko, Ito, Takanori, Hosaka, Tetsuya, Kawamura, Yusuke, Kuzuya, Teiji, Nojiri, Shunsuke, Ogawa, Chikara, Koga, Hironori, Hino, Keisuke, Ikeda, Masafumi, Moriguchi, Michihisa, Hisai, Takashi, Yoshimura, Kenichi, Furuse, Junji, Arai, Yasuaki
Published in Liver cancer (Basel ) (01.02.2024)
Published in Liver cancer (Basel ) (01.02.2024)
Get full text
Journal Article
A phase I pharmacokinetic study of lenvatinib in Chinese patients with unresectable hepatocellular carcinoma
Bai, Yuxian, Hu, Xichun, Ren, Zhenggang, Hisai, Takashi, Yusa, Wataru, Weng, Lidong, Shiba, Sari, Takase, Takao
Published in Future oncology (London, England) (01.07.2022)
Published in Future oncology (London, England) (01.07.2022)
Get full text
Journal Article
First‐in‐human study of E7130 (a tumor microenvironment‐ameliorating microtubule inhibitor) in patients with advanced solid tumors: Primary results of the dose‐escalation part
Doi, Toshihiko, Matsubara, Nobuaki, Naito, Yoichi, Kuboki, Yasutoshi, Harano, Kenichi, Ono, Makiko, Urasaki, Tetsuya, Ohmoto, Akihiro, Kawanai, Tsubasa, Hisai, Takashi, Ikezawa, Hiroki, Shiba, Sari, Ito, Ken, Semba, Taro, Asano, Osamu, Takahashi, Shunji
Published in Cancer (01.08.2023)
Published in Cancer (01.08.2023)
Get full text
Journal Article
A phase Ib study of lenvatinib (LEN) plus nivolumab (NIV) in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Study 117
Kudo, Masatoshi, Ikeda, Masafumi, Motomura, Kenta, Okusaka, Takuji, Kato, Naoya, Dutcus, Corina E., Hisai, Takashi, Suzuki, Mayumi, Ikezawa, Hiroki, Iwata, Takeyuki, Kumada, Hiromitsu, Kobayashi, Masahiro
Published in Journal of clinical oncology (01.02.2020)
Published in Journal of clinical oncology (01.02.2020)
Get full text
Journal Article
Subgroup analyses of a phase 1/2 study of lenvatinib (E7080), a multitargeted tyrosine kinase inhibitor, in patients (pts) with advanced hepatocellular carcinoma (HCC)
Ikeda, Masafumi, Ikeda, Kenji, Kudo, Masatoshi, Osaki, Yukio, Okusaka, Takuji, Tamai, Toshiyuki, Suzuki, Takuya, Hisai, Takashi, Miyagishi, Hideaki, Okita, Kiwamu, Kumada, Hiromitsu
Published in Journal of clinical oncology (01.02.2017)
Published in Journal of clinical oncology (01.02.2017)
Get full text
Journal Article
Assembly of extramembranous light-harvesting complexes of green sulfur photosynthetic bacterium Chlorobium tepidum on glass surface by electrostatic layer-by-layer adsorption
Saga, Yoshitaka, Kim, Tae-Yeun, Hisai, Takashi, Tamiaki, Hitoshi
Published in Thin solid films (03.04.2006)
Published in Thin solid films (03.04.2006)
Get full text
Journal Article